Skip to content

Century Therapeutics, Inc.

IPSC· NasdaqCore metricsCIK 1850119

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -7.43%
Market cap
$294.19M
181.6M shares
Filings
446
$109.16M
FY 2025+1,556.8% FY25 yoy
-$23.45M
Q3 2026N/M FY25 yoy
-$25.21M
Q3 2026N/M FY25 yoy
-$69.14M
Q3 2026derivedN/M FY25 yoy
-$0.11
Q3 2026N/M FY25 yoy
$45.02M
Q3 2026+5.8% FY25 yoy
$294.19M
—
2.7×
1.4×
-35.60%
—

FY2025 figures · derived

Price

$1.62+189.18%+$1.06past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$109.16MFY 2025
$109.16M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$109,164,000reported
FY 20242024-12-31$6,589,000reported
FY 20232023-12-31$2,235,000reported
FY 20222022-12-31$5,199,000reported

Biological products, except diagnostic substances

Century Therapeutics, Inc. is the 30th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Century Therapeutics, Inc. · CIK 1850119 · Engraved from SEC EDGAR